Friedel–Crafts Alkylation of Indoles
FULL PAPER
of charge from The Cambridge Crystallographic Data Centre via
1.08 ppm (s, 3H); 13C NMR (100 MHz, CDCl3): d=212.3, 141.1, 135.2,
128.6, 128.2, 127.7, 126.8, 125.2, 122.3, 121.9, 118.6, 112.8, 112.7, 76.4,
42.4, 37.6, 26.1, 25.9 ppm; HRMS (ESI): m/z: calcd for C20H21NO2
[M+H]+: 308.1645; found: 308.1639.
Compound 4 fa: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak IA column; hexane/2-propanol 85:15;
Compound 4ka: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak OD-H column; hexane/2-propanol 80:20;
1.0 mLminÀ1
,
254 nm):
t
(major)=19.50 min,
tRACTHNGUTERN(UNG minor)=26.51 min,
84% ee; [a]2D0 =À2.6 (c=0.15 in CH2Cl2). The absolute configuration was
1
assigned as R by analogy. H NMR (400 MHz, CDCl3): d=8.08 (br, 1H),
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG major)=22.49 min,
8.03–8.05 (m, 2H), 7.41 (d, J=8.8 Hz, 2H), 7.28 (t, J=7.2 Hz, 2H), 7.09–
7.13 (m, 1H), 6.95–6.99 (m, 2H), 4.97 (m, 1H), 3.27–3.41 (m, 3H), 1.19
(s, 3H), 1.14 ppm (s, 3H); 13C NMR (100 MHz, CDCl3): d=211.9, 151.6,
146.6, 136.6, 128.8, 126.0, 123.8, 122.7, 121.3, 119.9, 119.0, 117.4, 111.5,
76.4, 41.9, 37.6, 26.2 ppm; HRMS (ESI): m/z: calcd for C20H20N2O4
[M+H]+: 353.1496; found: 353.1501.
80% ee; [a]2D0 =À12.8 (c=0.18 in CH2Cl2). The absolute configuration
was assigned as R by analogy. 1H NMR (400 MHz, CDCl3): d=7.95 (br,
1H), 7.66–7.71 (m, 4H), 7.33–7.39 (m, 4H), 7.27 (d, J=8.0 Hz, 1H),
7.06–7.10 (m, 1H), 6.92–6.96 (m, 2H), 5.06 (t, J=7.2 Hz, 1H), 3.54 (s,
1H), 3.33–3.43 (m, 2H), 1.19 (s, 3H), 1.07 ppm (s, 3H); 13C NMR
(100 MHz, CDCl3): d=212.5, 142.0, 136.6, 133.4, 132.3, 128.2, 127.8,
127.6, 126.5, 126.4, 126.0, 125.9, 125.5, 122.3, 121.3, 119.6, 119.4, 118.8,
111.2, 76.4, 42.2, 37.9, 26.1, 26.0 ppm; HRMS (ESI): m/z: calcd for
C24H23NO2 [M+H]+: 358.1802; found: 358.1800.
Compound 4ga: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak AD-H column; hexane/2-propanol 80:20;
Compound 4la: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak OD-H column; hexane/2-propanol 90:10;
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG minor)=10.25 min,
85% ee; [a]2D0 =À23.1 (c=0.13 in CH2Cl2). The absolute configuration
was assigned as R by analogy. 1H NMR (400 MHz, CDCl3): d=7.99 (br,
1H), 7.34 (d, J=7.6 Hz, 1H), 7.26 (d, J=8.0 Hz, 1H), 7.21 (s, 1H), 7.06–
7.16 (m, 4H), 6.91–6.99 (m, 1H), 6.90 (s, 1H), 4.85 (t, 1J=7.2 Hz, 2J=
7.2 Hz, 1H), 3.53 (s, 1H), 3.20–3.31 (m, 2H), 1.19 (s, 3H), 1.09 ppm (s,
3H); 13C NMR (100 MHz, CDCl3): d=212.2, 145.8, 136.6, 134.3, 129.8,
127.9, 126.8, 126.2, 126.1, 122.5, 121.2, 119.7, 119.3, 118.2, 111.3, 76.4,
42.2, 37.5, 26.1, 26.0 ppm; HRMS (ESI): m/z: calcd for C20H20NO2Cl
[M+H]+: 342.1255; found: 342.1251.
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG major)=34.05 min,
43% ee; [a]2D0 =+12.0 (c=0.10 in CH2Cl2). 1H NMR (400 MHz, CDCl3):
d=8.00 (br, 1H), 7.48 (d, J=8.0 Hz, 1H), 7.23–7.27 (m, 2H), 7.08–7.13
(m, 1H), 6.96–6.99 (m, 2H), 6.18–6.20 (m, 1H), 5.98 (d, J=3.2 Hz, 1H),
4.94 (t, J=7.2 Hz, 1H), 3.64 (s, 1H), 3.33 (dd, 1J=8.0 Hz, 2J=17.2 Hz,
1H), 3.14 (dd, 1J=6.8 Hz, 2J=16.8 Hz, 1H), 1.20 (s, 3H), 1.08 ppm (s,
3H); 13C NMR (100 MHz, CDCl3): d=212.4, 156.2, 141.2, 136.4, 125.9,
122.3, 122.1, 119.6, 119.2, 116.1, 111.4, 110.3, 105.9, 76.5, 40.6, 32.1, 26.1,
25.8 ppm; HRMS (ESI): m/z: calcd for C18H19NO3 [M+H]+: 298.1438;
found: 298.1435.
Compound 4ha: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak AD-H column; hexane/2-propanol 85:15;
Compound 4ma: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was a known compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak OD-H column; hexane/2-propanol 80:20;
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG minor)=15.19 min,
84% ee; [a]2D0 =À28.3 (c=0.18 in CH2Cl2). The absolute configuration
was assigned as R by analogy. 1H NMR (400 MHz, CDCl3): d=8.13 (br,
1H), 7.33 (d, J=7.6 Hz, 1H), 7.26 (d, J=8.0 Hz, 1H), 7.03–7.18 (m, 3H),
6.81–6.99 (m, 3H), 6.76–6.79 (m, 1H), 4.87 (t, J=7.6 Hz, 1H), 3.30 (s,
1H), 3.25–3.27 (m, 2H), 1.19 (s, 3H), 1.09 ppm (s, 3H); 13C NMR
(100 MHz, CDCl3): d=212.3, 164.1, 161.7, 146.4 (d, J=66 Hz), 136.6,
129.9 (d, J=82 Hz), 126.3, 123.6 (d, J=27 Hz), 122.4, 121.2, 119.4 (d, J=
335 Hz), 118.2, 114.7 (d, J=221 Hz), 113.4 (d, J=210 Hz), 111.3, 76.4,
42.3, 37.5, 26.1, 26.0 ppm; HRMS (ESI): m/z: calcd for C20H20NO2F
[M+H]+: 326.1551; found: 326.1545.
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG minor)=10.15 min,
47% ee; [a]2D0 =+10.5 (c=0.19 in CH2Cl2). The absolute configuration
was assigned as S by comparison of the optical rotation with the reported
value (ref. [6h]: [a]2D5 =+27.2 (c=1.0 in CH2Cl2), 98% ee for S isomer).
1H NMR (400 MHz, CDCl3): d=8.07 (s, 1H), 7.64 (d, J=8.0 Hz, 1H),
7.34 (d, J=8.0 Hz, 1H), 7.08–7.25 (m, 7H), 7.06 (d, J=2.4 Hz, 1H), 3.70
(s, 1H), 3.58–3.65 (m, 1H), 3.07 (dd, J=6.8 Hz, 1H), 2.88 (dd, J=6.8 Hz,
1H), 2.50–2.57 (m, 2H), 2.02–2.19 (m, 2H), 1.29 (s, 3H), 1.04 ppm (s,
3H); 13C NMR (100 MHz, CDCl3): d=213.5, 142.2, 136.6, 128.4, 128.3,
126.3, 125.7, 122.0, 121.6,119.4, 119.3, 118.2, 111.4, 76.3, 42.6, 36.9, 34.1,
32.5, 26.2, 25.8 ppm.
Compound 4ia: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak AD-H column; hexane/2-propanol 90:10;
Compound 4ab: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak AD-H column; hexane/2-propanol 90:10;
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG minor)=34.15 min,
69% ee; [a]2D0 =À35.8 (c=0.12 in CH2Cl2). The absolute configuration
was assigned as R by analogy. 1H NMR (400 MHz, CDCl3): d=7.97 (br,
1H), 7.42 (d, J=8.0 Hz, 1H), 7.30–7.32 (m, 1H), 7.24 (d, J=8.0 Hz, 1H),
7.16–7.18 (m, 1H), 7.03–7.11 (m, 3H), 6.87–7.00 (m, 1H), 6.88 (s, 1H),
5.35 (t, J=7.2 Hz, 1H), 3.57 (s, 1H), 3.37 (dd, 1J=7.8 Hz, 2J=17.6 Hz,
1H), 3.22 (dd, 1J=6.8 Hz, 2J=17.6 Hz, 1H), 1.24 (s, 3H), 1.23 ppm (s,
3H); 13C NMR (100 MHz, CDCl3): d=211.9, 141.0, 136.5, 133.7, 129.9,
128.8, 127.8, 126.9, 126.5, 122.4, 121.7, 119.7, 119.4, 117.5, 111.2, 76.3,
41.3, 34.2, 26.5, 26.4 ppm; HRMS (ESI): m/z: calcd for C20H20NO2Cl
[M+H]+: 342.1255; found: 342.1261.
1.0 mLminÀ1
,
254 nm):
t
G
tRACTHNGUTERN(UNG minor)=23.26 min,
72% ee; [a]2D0 =+23.1 (c=0.13 in CH2Cl2). 1H NMR (400 MHz,
CD3COCD3): d=10.37 (br, 1H), 7.61 (s, 1H), 7.42–7.46 (m, 3H), 7.37 (d,
J=8.8 Hz, 1H), 7.30–7.33 (m, 2H), 7.19–7.22 (m, 1H), 4.86 (t, J=7.2 Hz,
1H), 4.38 (s, 1H), 3.51–3.63 (m, 2H), 1.23 (s, 3H), 1.22 ppm (s, 3H);
13C NMR (100 MHz, CD3COCD3): d=213.3, 144.9, 136.5, 132.1, 130.6,
129.5, 125.0, 124.3, 122.2, 118.9, 114.1, 112.5, 77.2, 43.2, 37.5, 26.7,
26.6 ppm; HRMS (ESI): m/z: calcd for C20H19NO2BrCl [M+H]+:
420.0360; found: 420.0357.
Compound 4ja: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak IA column; hexane/2-propanol 85:15;
Compound 4ac: The title compound was prepared according to the gen-
eral procedure and purified by chromatography to give a white solid,
which was an unknown compound. Chiral HPLC was performed using an
HP series 1200 (Chiralpak AD-H column; hexane/2-propanol 90:10;
1.0 mLminÀ1
,
254 nm):
t
(major)=10.56 min,
tRACTHNGUTERN(UNG minor)=13.47 min,
86% ee; [a]2D0 =À28.3 (c=0.12 in CH2Cl2). The absolute configuration
was assigned as R by analogy. 1H NMR (400 MHz, CDCl3): d=8.04 (br,
1H), 7.46 (d, J=2.0 Hz, 1H), 7.10–7.22 (m, 8H), 6.92 (d, J=2.4 Hz, 1H),
4.81 (t, J=7.2 Hz, 1H), 3.53 (s, 1H), 3.21–3.29 (m, 2H), 1.19 (s, 3H),
1.0 mLminÀ1
,
254 nm):
t
(minor)=18.31 min,
tRACTHNGUTERN(UNG major)=24.42 min,
Chem. Eur. J. 2010, 16, 1638 – 1645
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1643